Status:

RECRUITING

A Registry Study on Rimegepant for the Treatment of Migraine Participants in Guangdong-Hong Kong-Macao Greater Bay Area

Lead Sponsor:

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Conditions:

Migraine

Eligibility:

All Genders

18+ years

Brief Summary

This study is a single-arm, prospective, multicenter, observational registry study. It plans to enroll 120 migraine patients who meet the inclusion criteria and are treated with rimegepant in selected...

Eligibility Criteria

Inclusion

  • Participants with headaches that meet the diagnostic criteria for migraines according to the International Classification of Headache Disorders, 3rd edition (ICHD-3), with or without aura.
  • Patients prescribed rimegepant by the attending physician for the treatment of migraines.
  • Signed informed consent form.
  • Age greater than 18 years.
  • Not concurrently participating in other interventional clinical studies.

Exclusion

  • Patients diagnosed with secondary headaches.
  • Patients with severe visual, auditory, language, intellectual, memory, consciousness impairments or other conditions that prevent them from completing the questionnaire and follow-up.
  • Pregnant or lactating female patients.
  • Patients deemed by the investigator as unsuitable for participation in the study or unable to complete the 4-week follow-up.
  • Patients with a known history of hypersensitivity reactions to rimegepant or its components.
  • Evidence in the medical history suggesting the presence of uncontrolled or unstable cardiovascular diseases (such as ischemic heart disease, coronary artery vasospasm, or cerebrovascular ischemia), or a history of myocardial infarction, acute coronary syndrome, percutaneous coronary intervention, cardiac surgery, stroke, or transient ischemic attack within the past 6 months before the screening visit.

Key Trial Info

Start Date :

January 26 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 30 2024

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT06221267

Start Date

January 26 2024

End Date

June 30 2024

Last Update

April 11 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University

Guangzhou, Guangdong, China, 510120